Healing and preventing the diabetic foot wound: where technology, economics and common sense converge.
Armstrong
D G
DG
D043925:Angiogenesis Inducing Agents / Q000191:economics / Q000627:therapeutic use; D000077214:Becaplermin; D017719:Diabetic Foot / Q000188:drug therapy* / Q000191:economics* / Q000517:prevention & control; D016527:Drug Costs; D006801:Humans; D010982:Platelet-Derived Growth Factor / Q000191:economics* / Q000627:therapeutic use*; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use; D014481:United States; D014945:Wound Healing / Q000187:drug effects
D043925:Angiogenesis Inducing Agents; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D000077214:Becaplermin